Promatix

Promatix is a biotechnology company focused on developing innovative therapeutics, specifically targeting cancer treatment. The company utilizes a multi-omics platform that encompasses proteomic, genomic, and transcriptomic data to discover and validate new therapeutic targets. By analyzing differential protein expression in both diseased and normal tissues, Promatix aids medical companies in identifying potential drug targets at a protein level. Their proprietary technology, TxPro, enhances the validation process, contributing to the development of effective cancer treatments. Through these efforts, Promatix aims to advance the field of oncology by providing novel solutions for drug development.